Other
Technologies
OnCell IT
is another version of InCell IT, where the target proteins of the interest are
membrane bound proteins. Whereas InCell IT is a technology focused oncytolsolic proteins, OnCell IT will allow us to monitor the ligand-membrane boundprotein (e.g. GPCR) Development of OnCell IT is in progress and will be filedfor domestic patent soon.
- Intracellular
Delivery Tehcnology
1) ITT (Intracellular
Transduction Technology):
ITT is CGK¡¯s proprietary technology developed to enable delivery of varioustypes of substances into cells. CGK has developed a library of delivery agent
from which one can select the suitable agent depending on the characteristics
of the cargo. ITT was originally developed to enable the delivery of magneticnanoparticle into cells for InCell IT Technology and later extended to a
library of delivery agent. ITT can deliver many different types of biomoleculesincluding proteins, particles, peptides and small molecules. ITTcan be appliedto DDS (drug delivery system), development of incrementally modified drug and
delivery of ingredients in cosmeceutical products.
2) Intellisome:
Intellisome is another proprietary delivery agent developed for intracellular
delivery of cargos.
- Nanobio
Technology: Nanomaterial Engineering
CGK
has developed technology to produce biocompatible nanoparticles of subcellular
size for various biological applications. It can be applied to cell &
molecule separation, biomolecule delivery, bio-imaging (including stem cell
tracking).
